Stock Price
32.77
Daily Change
-0.25 -0.74%
Monthly
-7.47%
Yearly
-5.93%
Q2 Forecast
31.51

ResMed reported $59K in Interest Income for its fiscal quarter ending in June of 2021.





Interest Income Change Date
Ansell USD 2.6M 800K Jun/2024
Cochlear AUD 7.4M 2.2M Dec/2024
CSL USD 18M 1000K Dec/2024
Integral Diagnostics AUD 482K 103K Jun/2024
Nanosonics AUD 2.89M 230K Dec/2024
ResMed USD 59K 4K Jun/2021
Telix Pharmaceuticals AUD 1.37M 354K Jun/2024